12 West Capital Management LP Maravai Lifesciences Holdings, Inc. Transaction History

12 West Capital Management LP

$610 Million
Q1 2025

A detailed history of 12 West Capital Management LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, 12 West Capital Management LP holds 12,521,335 shares of MRVI stock, worth $27.9 Million. This represents 4.53% of its overall portfolio holdings.

Number of Shares

12,521,335

Previous 11,591,335 8.02%

Holding current value

$27.9 Million

Previous $63.2 Million 56.2%

% of portfolio

4.53%

Previous 6.99%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.21 - $6.13 $2.06 Million - $5.7 Million	930,000 Added 8.02%	12,521,335 $27.7 Million
Q4 2024 Feb 13, 2025	SELL	$4.42 - $8.5 $10.7 Million - $20.6 Million	-2,419,844 Reduced 17.27%	11,591,335 $63.2 Million
Q3 2024 Nov 13, 2024	BUY	$6.84 - $9.73 $5.47 Million - $7.78 Million	800,000 Added 6.06%	14,011,179 $116 Million
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $56,272 - $92,885	8,191 Added 0.06%	13,211,179 $94.6 Million
Q1 2024 May 07, 2024	BUY	$5.11 - $8.76 $8.18 Million - $14 Million	1,600,000 Added 13.79%	13,202,988 $114 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $24.2 Million - $50.7 Million	5,139,877 Added 79.53%	11,602,988 $76 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $28.3 Million - $39.9 Million	3,101,275 Added 92.25%	6,463,111 $64.6 Million
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $9.59 Million - $11.9 Million	793,066 Added 30.87%	3,361,836 $41.8 Million
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $33.4 Million - $42.3 Million	2,568,770 New	2,568,770 $36 Million

Others Institutions Holding MRVI

# of Institutions

208

Shares Held

129M

Call Options Held

267K

Put Options Held

648K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $293M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on 12 West Capital Management LP with notifications on news.

Account

12 West Capital Management LP Maravai Lifesciences Holdings, Inc. Transaction History